药物开发与技术 SCIESCI

期刊简介预计审稿时间：约1.0个月

Pharmaceutical Development & Technology publishes research on the design, development, manufacture, and evaluation of conventional and novel drug delivery systems, emphasizing practical solutions and applications to theoretical and research-based problems. The journal aims to publish significant, innovative and original research to advance the frontiers of pharmaceutical development and technology.

Through original articles, reviews (where prior discussion with the EIC is encouraged), short reports, book reviews and technical notes, Pharmaceutical Development & Technology covers aspects such as:

-Preformulation and pharmaceutical formulation studies

-Pharmaceutical materials selection and characterization

-Pharmaceutical process development, engineering, scale-up and industrialisation, and process validation

-QbD in the form a risk assessment and DoE driven approaches

-Design of dosage forms and drug delivery systems

-Emerging pharmaceutical formulation and drug delivery technologies with a focus on personalised therapies

-Drug delivery systems research and quality improvement

-Pharmaceutical regulatory affairs

This journal will not consider for publication manuscripts focusing purely on clinical evaluations, botanicals, or animal models.

Pharmaceutical Development & Technology 发表关于传统和新型药物输送系统的设计、开发、制造和评估的研究，强调理论和研究问题的实际解决方案和应用。该杂志旨在发表重要的、创新的和原创的研究，以推进药物开发和技术的前沿。

通过原创文章、评论（鼓励事先与 EIC 讨论）、简短报告、书评和技术说明，药物开发与技术涵盖以下方面：

-预制剂和药物制剂研究

-药材选择与表征

-制药工艺开发、工程、放大和工业化以及工艺验证

-QbD 形式为风险评估和 DoE 驱动的方法

-剂型和给药系统的设计

-专注于个性化治疗的新兴药物配方和给药技术

-给药系统研究和质量改进

-药品监管事务

本期刊不考虑发表纯粹关注临床评估、植物药或动物模型的手稿。

《Pharmaceutical Development And Technology》(药物开发与技术)编辑部通讯方式为TAYLOR & FRANCIS INC, 325 CHESTNUT ST, SUITE 800, PHILADELPHIA, USA, PA, 19106。如果您需要协助投稿或润稿服务，您可以咨询我们的客服老师。我们专注于期刊投稿服务十年，熟悉发表政策，可为您提供一对一投稿指导，避免您在投稿时频繁碰壁，节省您的宝贵时间，有效提升发表机率，确保SCI检索（检索不了全额退款）。我们视信誉为生命，多方面确保文章安全保密，在任何情况下都不会泄露您的个人信息或稿件内容。